Reckitt Benckiser Group PLC (RB.L)
4,653.00GBp
7:47am EDT
-64.00p (-1.36%)
4,717.00p
4,726.00p
4,728.00p
4,651.00p
385,506
1,225,811
4,986.00p
3,512.00p
About
Overall
| Beta: | 0.31 |
| Market Cap (Mil.): | £33,856.90 |
| Shares Outstanding (Mil.): | 717.76 |
| Dividend: | 60.00 |
| Yield (%): | 2.93 |
Financials
| RB.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 20.18 | 47.70 | 40.02 |
| EPS (TTM): | 2.34 | -- | -- |
| ROI: | 20.25 | 91.22 | 66.25 |
| ROE: | 29.67 | 99.83 | 72.62 |
Health and hygiene focus helps Reckitt lift sales
LONDON - Reckitt Benckiser's focus on health and hygiene products is paying off, the consumer goods group said on Monday, as demand for brands such as Durex condoms and Dettol disinfectants helped it to nudge up its annual sales forecast.
UPDATE 2-Health and hygiene focus helps Reckitt lift sales
LONDON, July 29 - Reckitt Benckiser's focus on health and hygiene products is paying off, the consumer goods group said on Monday, as demand for brands such as Durex condoms and Dettol disinfectants helped it to nudge up its annual sales forecast.
Reckitt sales rise, sees full-year at top of range
LONDON, July 29 - British consumer goods group Reckitt Benckiser reported a 6 percent rise in first half sales and said it expected revenue growth at the top end of guidance for the full-year.
UPDATE 1-South Africa orders recall of Reckitt's Dettol disinfectant liquid
JOHANNESBURG, July 23 - South Africa on Tuesday ordered a recall of Dettol brand disinfectant liquid made by Britain's Reckitt Benckiser, saying the product used to fight household germs was not safe for consumer use.
South Africa orders recall of Reckitt's Dettol disinfectant liquid
JOHANNESBURG, July 23 - South Africa on Tuesday ordered a recall of Dettol brand disinfectant liquid made by Britain's Reckitt Benckiser, saying the product used to fight household germs was not safe for consumer use.
Britain's FTSE rises, lifted by demand for defensives
LONDON, June 17 - Britain's top share index rose on Monday, as demand for safe-haven consumer staples helped to lift the FTSE 100 off of six week lows ahead of a U.S. monetary policy meeting later this week.
FDA rejects Titan drug for opioid dependence
- U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals Inc and asked for additional data showing it works, the company said.
UPDATE 2-FDA rejects Titan drug for opioid dependence
* Titan says extremely surprised and disappointed by ruling
PRESS DIGEST - Financial Times - April 23
April 22 - Headlines Bumi shares halted amid payments concern () Bribery probe lifts Walmart directors' pay ()
Severe U.S. flu season helps Reckitt top forecasts
LONDON - A severe U.S. cold and flu season helped Reckitt Benckiser , the maker of Strepsils lozenges and Mucinex decongestant, to beat first-quarter revenue expectations.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

